Early research (Phase 1)Active Not RecruitingNCT06632236
What this trial is testing
5G-EMERALD: Amivantamab in Malignant Brain Tumours
Who this might be right for
Malignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more
Institute of Cancer Research, United Kingdom 12